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Antimicrobial effect of the essential oil from Rosmarinus officinalis L. 
against Staphylococcus pseudintermedius isolated from dogs
ABSTRACT: (Antimicrobial effect of the essential oil from Rosmarinus officinalis L. against Staphylococcus pseudintermedius 
isolated from dogs). This study evaluated the inhibitory effect of Rosmarinus officinalis L. (rosemary) essential oil (ROEO) 
against 18 isolates of Staphylococcus pseudintermedius isolated from dogs affected by pyoderma in Brazil, by determining the 
minimum inhibitory concentrations (MIC) and the effects on the bacterial cell viability over 16 h. MIC values of ROEO against 
the isolates were 2.5 µL/mL (3/18), 5 µL/mL (12/18) or 10 µL/mL (3/18). At all concentrations tested  (¼, ½, 1x, 2x and 4x MIC) 
the ROEO inhibited  bacterial cell viability after 30 min of exposure, and no recovery in viable cell counts was noted in the later 
intervals. The ROEO at ½, 1x, 2x and 4x MIC established its bactericidal effect within a maximum exposure time of 16 h. These 
findings reveal an interesting anti-S. pseudintermedius effect of ROEO, with a rapid and steady kill rate. 
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RESUMO: (Efeito antimicrobiano do óleo essencial de Rosmarinus officinalis L. contra Staphylococcus pseudintermedius 
isolados de cães). O objetivo deste trabalho foi avaliar o efeito inibitório do óleo essencial de Rosmarinus officinalis L. (alecrim) 
(OERO) frente a 18 linhagens Staphylococcus pseudintermedius isoladas de cães com piodermite no Brasil, determinando a 
concentração inibitória mínima (CIM) e os efeitos da viabilidade da célula bacteriana, durante 16 horas. Os valores da CIM do 
OERO, frente aos isolados avaliados, foram 2,5 µL/mL (3/18), 5 µL/mL (12/18) ou 10 µL/mL (3/18). Em todas as concentra-
ções testadas (¼, ½, 1x, 2x e 4x CIM), o OERO causou inibição da viabilidade celular já após 30 minutos de exposição e não 
foi constatado restabelecimento da viabilidade celular na contagem de células viáveis nos intervalos mais tardios avaliados. O 
OERO exerceu atividade bactericida a partir da concentração 1/2 CIM. Esses resultados revelam um interessante efeito anti-S. 
pseudointermedius do OERO com uma rápida e constante taxa bactericida.
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INTRODUCTION
Staphylococcus pseudintermedius (formerly Staphylo-
coccus intermedius; Devriese et al. 2009), a coagulase-
-positive staphylococcus, forms part of the indigenous 
microflora of cats, minks, pigeons, horses and mainly 
dogs, where this bacterium colonizes the upper respi-
ratory tract, skin and mucosal surfaces. Staphylococcus 
pseudintermedius may also act as invasive pathogen, 
causing pyoderma, otitis, cystitis and osteomyelitis (Pen-
na et al. 2010, Pereira et al. 2009, Oliveira et al. 2006, 
Girard & Higgins 1999). Although rarely isolated from 
humans, S. pseudintermedius is known as a zoonotic 
pathogen that causes some infections of canine-inflicted 
wound infections and other invasive and non-invasive 
infections in humans (Pottumarthy et al. 2004, Mahou-
deau et al. 1997).
Resistance of S. pseudintermedius to classical antibio-
tics used in clinical veterinary therapy is now a factual 
reality, related to their wide use over time (Futagawa-
-Saito et al. 2007, Lima et al. 2012). Regarding the 
increasing clinical importance of the development of 
drug resistance in S. pseudintermedius, there is a need 
to discover new and effective antimicrobial agents to 
control this bacterium.
Currently, there has been increasing interest in stu-
dying the biological properties of plants and derivatives 
in order to find alternative antimicrobial compounds. 
Rosmarinus officinalis L. (Lamiaceae), commonly 
known as rosemary, is a popular herb in many western 
countries and is widely used in folk medicine, cosmetics 
and phytopharmacy (Bozin et al. 2007). More than 30 
compounds have been identified in the essential oil from 
R. officinalis  (ROEO), although one study found that 
α-pinene, 1,8-cineole, camphor, verbenone and borneol 
comprised approximately 80 g/100 g of the total essential 
oil  (Santoyo et al. 2005).
The aim of this study was to evaluate the inhibitory 
effect of the ROEO against isolates of S. pseudinterme-
dius from dogs affected by pyoderma in Brazil. 
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MATERIAL AND METHODS 
Essential oil
ROEO was supplied by Ferquima Ltda. (Vargem Gran-
de Paulista, SP, Brazil) and its quality parameters were 
described in an accompanying technical report (density 
0.919; refraction index 1.465; major components: 1,8-ci-
neole, 47 g/100 g; camphor, 16.7 g/100 g; and α-pinene, 
13.5 g/100 g). The stock solution of the ROEO was 
prepared in sterile distilled water using Tween 80 at 4 
g/100 mL (Sigma Chemical Co., USA) as a stabilizing 
agent. Tween 80 at its highest final concentration after 
dilution in Brain Heart Infusion (BHI) broth (0.5 g/100 
mL) caused no inhibition of the bacterial growth.
Bacterial isolates
Eighteen isolates of S. pseudintermedius were obtained 
from superficial lesions of dogs affected by pyoderma 
in a private veterinary clinic in the city of Natal (Rio 
Grande do Norte State, Brazil). The isolates were iden-
tified as coagulase positive staphylococci by standard 
microbiological procedures, and were differentiated 
in particular from S. aureus by exhibiting sensitivity 
to polymyxin B, lack of acid production from maltose 
aerobically (Devriese et al. 2005) and from mannitol 
aerobically and anaerobically (Roberson et al.1992), lack 
of acetoin production in MR-VP medium (Laboratórios 
Difco Ltda., Brazil) with added of creatine at 0.06 g/100 
mL (Sigma Chemical Co., USA) (Roberson et al. 1992, 
Devriese et al. 2005), lack of growth in Baird-Parker Agar 
(Laboratórios Difco Ltda., Brazil) with added potassium 
telluride at 0.1 g/100 mL (Sigma Chemical Co., USA) 
(Raus & Love 1983) and lack of growth in Brain Heart 
Infusion (BHI) Agar (Laboratórios Difco Ltda., Brazil) 
with added acriflavine at 7 µg/mL (Sigma Chemical Co., 
USA) (Roberson et al.,1992). The isolates were main-
tained in Stock Culture Agar (Difco Becton Dicknson, 
USA), and prior to use, the cells were grown overnight 
at 37°C in BHI.
Susceptibility testing
The Minimum Inhibitory Concentration (MIC) of the 
ROEO was determined in BHI (Laboratórios Difco Ltda., 
Brazil) by the macrodilution assay using a bacterial sus-
pension of ca. 105 cfu/mL, and an ROEO concentration 
ranging from 10 - 0.62 µL/mL (twofold serial dilutions) 
(Barros et al. 2009). MIC was defined as the lowest 
concentration at which no growth was observed. 
Time-kill assay 
The bacteria were grown in Mueller-Hinton broth 
(Laboratórios Difco Ltda., Brazil) until they reached the 
late exponential phase (16-18 h at 37 ºC) and were resus-
pended in the same medium at a density of ca. 106 cfu/
mL. The ROEO was added to obtain final concentrations 
of ¼ MIC, ½ MIC, 1x MIC, 2x MIC and 4x MIC, and 
the cultures were incubated at 37 ºC. Next, 0, ½, 1, 2, 4, 
8 and 16 h aliquots (100 µL) were taken, serially diluted 
in saline solution (0.85 g/100 mL) and spread-plated 
onto Mueller-Hinton agar (Laboratórios Difco Ltda., 
Brazil) (Barros et al. 2009). After 24 h of incubation at 
37 ºC, colonies were counted and the relative bacterial 
titer calculated (bacterial titer at time t / bacterial titer at 
time 0). Assays without adding the ROEO to the growth 
media were tested similarly as positive control.   
RESULTS AND DISCUSSION
MIC values of ROEO against the 18 isolates of S. 
pseudintermedius were 2.5 µL/mL (3/18), 5 µL/mL 
(12/18) or 10 µL/mL (3/18). Previous studies found that 
the efficacy of ROEO in inhibiting a variety of classical 
and opportunistic pathogens depends on the plant loca-
tion and seasonal variations, the method of extraction of 
the essential oil, the procedure used in the antimicrobial 
assays, and the target microbial isolate (Gachkar et al. 
2007, Santoyo et al. 2005). 
The effect of different concentrations of ROEO on the 
cell viability of S. pseudintermedius (S28; MIC: 5 µL/
mL) is shown in Figure 1. 
All time-kill assays were repeated three times, with 
consistent results (standard error ≤ 12.6%). At all con-
centrations tested, the ROEO caused inhibition of the 
bacterial cell viability already after 30 min of exposure, 
and no recovery in viable cell counts was noted in the 
later evaluated exposure times. The ROEO at ½ MIC, 
MIC, 2x MC and 4x MIC established their bacteri-
cidal effect (≥3 log10 reduction of the initial inocula, i.e., 
≥99.9% kill; LaPlante 2007) at a maximum exposure time 
of 16 h. However, after 16 h of exposure the ROEO at 
¼ MIC decreased the viable cell counts in 2 log cycles 
(i.e.,90% kill). ROEO at 4x MIC and 2x MIC revealed 
the fastest bactericidal effect, noted after 1 and 3 h of 
exposure, respectively. 
The anti-S. pseudintermedius activity of ROEO has not 
been previously reported. Even regarding S. aureus, time-
-kill curves of ROEO had not been reported before the 
studies of Gachkar et al. (2007) and Fu et al. (2007). The 
results reported here revealed a rapid and steady kill rate 
of the ROEO tested, and a dose- and time-dependent bac-
tericidal effect against S. pseudintermedius. Interestingly, 
Ganière et al. (2004) found a steady bactericidal effect 
of orbifloxacin (at 2 x MIC) toward S. pseudintermedius 
after 10 h of exposure. Orbifloxacin is a fluorquinolone 
that is exclusively used in veterinary medicine and is 
frequently applied in the treatment of pyoderma.
Besides the likely safety of ROEO when used topi-
cally, some researchers have suggested that the risk of 
development of bacterial resistance to it is low because of 
the multicomponent nature of essential oils (Patriginani 
et al. 2008). 
The results obtained in this study show an interesting 
anti-S. pseudintermedius effect of ROEO, which may 
show promise for inclusion in topical formulations used 
to eradicate S. pseudintermedius in animal infections, 
particularly in pyoderma. 
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